Opinion: OA Coming of Age

Open-access journals are reaching the same quality levels as their subscription counterparts.

Written byDavid Solomon and Bo-Christer Björk
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Many scientists and publishers have questioned the quality of open-access (OA) journals. Initially their concerns may have been justified, as most of the original OA journals were created and operated by academics with little experience in publishing and often very limited resources. While some of these early experiments in open-access publishing resulted in excellent journals, many did not and often disappeared quickly. Unfortunately this attrition gave OA publishing a bad reputation.

Since the launching of the Public Library of Science (PLoS) and BioMed Central (BMC) about a decade ago as the first professional OA publishers, the reputation of OA publishing has begun to change. Our study, which was recently published in BMC Medicine, confirms what many have suspected for quite some time—that the better OA journals are on par with their subscription counterparts.

We compared approximately 600 OA journals with 7,500 subscription journals using Web of Science citation data. (Full ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies